Susquehanna International Group, LLP Enzo Biochem Inc Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Enzo Biochem Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 33,835 shares of ENZ stock, worth $17,594. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,835Holding current value
$17,594% of portfolio
0.0%Shares
21 transactions
Others Institutions Holding ENZ
# of Institutions
50Shares Held
16.6MCall Options Held
18.3KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$2.69 Million1.92% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.37MShares$1.23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$966,6810.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$770,5053.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$693,9299.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $25.3M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...